Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Brachial Artery Flow-mediated Dilation clinical trials

1 of 1 indexed Brachial Artery Flow-mediated Dilation trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Brachial Artery Flow-mediated Dilation: 1 US clinical trial tracked, 1 recruiting.

Brachial Artery Flow-mediated Dilation is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is University of Minnesota, running 1 of these trials.

Enrollment posture brief

Registry condition brachial-artery-flow-mediated-dilation

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Brachial Artery Flow-med (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Brachial Artery Flow-mediated Dilation

Brachial Artery Flow-mediated Dilation lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Brachial Artery Flow-mediated Dilation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Brachial Artery Flow-mediated Dilation is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Brachial Artery Flow-mediated Dilation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

POWERbreathe K5 Device
1 trials

US sites by state

Facility locations filed on Brachial Artery Flow-mediated Dilation trials. A trial with sites in several states counts in each.

Minnesota 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Brachial Artery Flow-mediated Dilation page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Brachial Artery Flow-mediated Dilation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • University of Minnesota sponsors the most Brachial Artery Flow-mediated Dilation trials on record, review their full trial history before evaluating a specific study. See University of Minnesota's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Brachial Artery Flow-mediated Dilation condition card totals 1 registered trials; most-linked intervention POWERbreathe K5; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.